Laboratory Proficiency Testing Market to hit USD 2.2
Laboratory Proficiency Testing Industry is projected to witness a CAGR of 6.1% during the period 2023-2032. This growth can be attributed to the increasing...
Stay updated with breaking news from Analytical Performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Laboratory Proficiency Testing Industry is projected to witness a CAGR of 6.1% during the period 2023-2032. This growth can be attributed to the increasing...
SPECTRO Analytical Instruments has introduced the SPECTROMAXx LMX10 ARC/SPARK OES analyzer for fast, accurate, advanced elemental analysis in metal producing and fabricating plants, and iron and non-ferrous foundries.
Kleve, Germany, June 30, 2022 – SPECTRO Analytical Instruments has introduced the SPECTROMAXx LMX10 ARC/SPARK OES analyzer for fast, accurate, advanced elemental analysis in metal producing and fabricating plants, and iron and non-ferrous foundries. The LMX10 is the newest version of SPECTROMAXx, perhaps the industry’s best-selling arc/spark optical emission spectrometry (OES) analyzer. SPECTROMAXx delivers outstanding repeatability, reproducibility, and…
To embed, copy and paste the code into your website or blog: After having dealt with the issue when software may be considered a medical device according to its intended purpose (in part 2) and the implications of the new risk classification regime (in part 3), in this part 4 of our series on Software as a Medical Device in Europe, we will now explore key changes to the quality assurance and documentation requirements for stand-alone medical device software (“ MDR”). INTRODUCTION: A NEW LIFE CYCLE-FOCUSED APPROACH MDD”) primarily focusses on the pre-approval stage of a medical device...